Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.440
-0.110 (-7.10%)
At close: Oct 24, 2024, 4:00 PM
1.400
-0.040 (-2.78%)
After-hours: Oct 24, 2024, 4:58 PM EDT
Chemomab Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 3.48 | 7.08 | 11.56 | 6.03 | 1.29 | 0.96 | |
| Research & Development | 12.55 | 18.38 | 16.98 | 6.33 | 4.68 | 5.82 | |
| Operating Expenses | 16.03 | 25.46 | 28.53 | 12.37 | 5.97 | 6.78 | |
| Operating Income | -16.03 | -25.46 | -28.53 | -12.37 | -5.97 | -6.78 | |
| Interest Expense | - | - | - | -0.11 | - | -0 | |
| Interest & Investment Income | 0.99 | 1.25 | 0.96 | - | 0.04 | - | |
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.61 | - | -0.02 | - | |
| Pretax Income | -15.05 | -24.22 | -28.18 | -12.48 | -5.95 | -6.78 | |
| Income Tax Expense | -0.06 | - | -0.53 | - | - | - | |
| Net Income | -15 | -24.22 | -27.65 | -12.48 | -5.95 | -6.78 | |
| Net Income to Common | -15 | -24.22 | -27.65 | -12.48 | -5.95 | -6.78 | |
| Shares Outstanding (Basic) | 13 | 12 | 11 | 10 | 7 | - | |
| Shares Outstanding (Diluted) | 13 | 12 | 11 | 10 | 7 | - | |
| Shares Change (YoY) | 19.04% | 3.26% | 9.70% | 51.71% | - | - | |
| EPS (Basic) | -1.12 | -2.06 | -2.43 | -1.20 | -0.87 | - | |
| EPS (Diluted) | -1.12 | -2.06 | -2.43 | -1.20 | -0.87 | - | |
| Free Cash Flow | -16.13 | -23.61 | -20.44 | -12.61 | -5.28 | -6.63 | |
| Free Cash Flow Per Share | -1.21 | -2.01 | -1.80 | -1.22 | -0.77 | - | |
| EBITDA | -15.97 | -25.39 | -28.48 | -12.33 | -5.95 | -6.76 | |
| D&A For EBITDA | 0.06 | 0.07 | 0.06 | 0.03 | 0.02 | 0.02 | |
| EBIT | -16.03 | -25.46 | -28.53 | -12.37 | -5.97 | -6.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.